Net Income Summary of Cipla Limited

Cipla Limited's latest annual net income in 2023 was 41.21 Billion INR , up 47.1% from previous year.
Cipla Limited's latest quarterly net income in 2024 Q1 was 11.77 Billion INR , up 25.41% from previous quarter.
Cipla Limited reported an annual net income of 28.01 Billion INR in 2022, up 11.33% from previous year.
Cipla Limited reported an annual net income of 25.16 Billion INR in 2021, up 4.65% from previous year.
Cipla Limited reported a quarterly net income of 13.02 Billion INR for 2024 Q2, up 10.61% from previous quarter.
Cipla Limited reported a quarterly net income of 9.95 Billion INR for 2023 Q1, up 89.42% from previous quarter.

Annual Net Income Chart of Cipla Limited (2023 - 2003)

Historical Annual Net Income of Cipla Limited (2023 - 2003)

Year	Net Income	Net Income Growth
2023	41.21 Billion INR	47.1%
2022	28.01 Billion INR	11.33%
2021	25.16 Billion INR	4.65%
2020	24.04 Billion INR	55.5%
2019	15.46 Billion INR	1.23%
2018	15.27 Billion INR	8.31%
2017	14.1 Billion INR	40.16%
2016	10.06 Billion INR	-26.0%
2015	13.59 Billion INR	15.18%
2014	11.8 Billion INR	-14.96%
2013	13.88 Billion INR	-10.13%
2012	15.44 Billion INR	35.01%
2011	11.44 Billion INR	15.63%
2010	9.89 Billion INR	-8.59%
2009	10.82 Billion INR	40.41%
2008	7.71 Billion INR	9.98%
2007	7.01 Billion INR	4.98%
2006	6.67 Billion INR	9.9%
2005	6.07 Billion INR	48.35%
2004	4.09 Billion INR	33.56%
2003	3.06 Billion INR	0.0%

Year	Net Income	Net Income Growth
2024 Q1	11.77 Billion INR	25.41%
2024 Q2	13.02 Billion INR	10.61%
2023 Q1	9.95 Billion INR	89.42%
2023 Q2	11.3 Billion INR	13.58%
2023 FY	41.21 Billion INR	47.1%
2023 Q4	9.39 Billion INR	-11.07%
2023 Q3	10.55 Billion INR	-6.63%
2022 FY	28.01 Billion INR	11.33%
2022 Q2	7.88 Billion INR	14.93%
2022 Q3	8 Billion INR	1.53%
2022 Q1	6.86 Billion INR	89.58%
2022 Q4	5.25 Billion INR	-34.37%
2021 Q3	7.28 Billion INR	2.42%
2021 FY	25.16 Billion INR	4.65%
2021 Q1	7.14 Billion INR	72.9%
2021 Q2	7.11 Billion INR	-0.47%
2021 Q4	3.62 Billion INR	-50.31%
2020 Q1	5.77 Billion INR	134.97%
2020 Q2	6.65 Billion INR	15.14%
2020 Q3	7.48 Billion INR	12.43%
2020 FY	24.04 Billion INR	55.5%
2020 Q4	4.13 Billion INR	-44.75%
2019 Q1	4.78 Billion INR	30.23%
2019 FY	15.46 Billion INR	1.23%
2019 Q2	4.71 Billion INR	-1.43%
2019 Q3	3.51 Billion INR	-25.53%
2019 Q4	2.45 Billion INR	-29.93%
2018 Q3	3.32 Billion INR	-11.89%
2018 Q1	4.51 Billion INR	152.65%
2018 FY	15.27 Billion INR	8.31%
2018 Q4	3.67 Billion INR	10.54%
2018 Q2	3.77 Billion INR	-16.44%
2017 Q1	4.08 Billion INR	761.63%
2017 FY	14.1 Billion INR	40.16%
2017 Q3	4 Billion INR	-5.22%
2017 Q4	1.78 Billion INR	-55.4%
2017 Q2	4.22 Billion INR	3.37%
2016 Q4	-617.9 Million INR	-116.49%
2016 FY	10.06 Billion INR	-26.0%
2016 Q1	3.39 Billion INR	465.25%
2016 Q3	3.74 Billion INR	5.78%
2016 Q2	3.54 Billion INR	4.51%
2015 Q4	-928.3 Million INR	-135.63%
2015 Q3	2.6 Billion INR	-52.01%
2015 Q2	5.43 Billion INR	-16.36%
2015 Q1	6.49 Billion INR	150.03%
2015 FY	13.59 Billion INR	15.18%
2014 Q2	2.98 Billion INR	1.39%
2014 FY	11.8 Billion INR	-14.96%
2014 Q4	2.59 Billion INR	-20.8%
2014 Q3	3.27 Billion INR	9.77%
2014 Q1	2.94 Billion INR	13.0%
2013 Q3	2.84 Billion INR	-20.6%
2013 Q4	2.6 Billion INR	-8.31%
2013 Q2	3.58 Billion INR	-26.23%
2013 FY	13.88 Billion INR	-10.13%
2013 Q1	4.85 Billion INR	75.54%
2012 FY	15.44 Billion INR	35.01%
2012 Q1	4.4 Billion INR	0.0%
2012 Q2	4.87 Billion INR	10.87%
2012 Q3	3.4 Billion INR	-30.26%
2012 Q4	2.76 Billion INR	-18.75%
2011 FY	11.44 Billion INR	15.63%
2010 FY	9.89 Billion INR	-8.59%
2009 FY	10.82 Billion INR	40.41%
2008 FY	7.71 Billion INR	9.98%
2007 FY	7.01 Billion INR	4.98%
2006 FY	6.67 Billion INR	9.9%
2005 FY	6.07 Billion INR	48.35%
2004 FY	4.09 Billion INR	33.56%
2003 FY	3.06 Billion INR	0.0%

Peer Net Income Comparison of Cipla Limited

Name	Net Income	Net Income Difference
Abbott India Limited	12.01 Billion INR	-243.114%
Gland Pharma Limited	7.72 Billion INR	-433.562%
GlaxoSmithKline Pharmaceuticals Limited	5.89 Billion INR	-598.614%
Kopran Limited	509.56 Million INR	-7988.417%
Marksans Pharma Limited	3.13 Billion INR	-1213.851%
NGL Fine-Chem Limited	413.16 Million INR	-9875.506%
Pfizer Limited	5.51 Billion INR	-647.565%
Sanofi India Limited	6.02 Billion INR	-583.621%
SMS Pharmaceuticals Limited	498.26 Million INR	-8171.886%

Global Stocks Search

Cipla Limited (CIPLA.BO)

Net Income Summary of Cipla Limited

Annual Net Income Chart of Cipla Limited (2023 - 2003)

Historical Annual Net Income of Cipla Limited (2023 - 2003)

Peer Net Income Comparison of Cipla Limited